Inventor · disambiguated record
Alfonso Zambon
Also filed as: ZAMBON ALFONSO
16 granted patents·1 pending application·89 citations·filing 2008–2022
92Inventor score
Files withCANCER REC TECH LTD3CANCER RES TECH LTD3CANCER RESEARCH TECH LTD3SPRINGER CAROLINE JOY2THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL2
Top patents by PatentIndex Score
17 records- 0190US8198279B2Pyrido[2,3-b]pyrazin-8-substituted compounds and their useSPRINGER CAROLINE JOY·Filed 2008·Granted Jun 12, 2012·18 cites·34 claims
- 0288US9120789B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyCANCER REC TECH LTD·Filed 2014·Granted Sep 1, 2015·7 cites·39 claims
- 0387US9155737B2Pyrido[2,3-B]pyrazin-8-substituted compounds and their useCANCER RES INST ROYAL·Filed 2014·Granted Oct 13, 2015·8 cites·33 claims
- 0487US8912191B2Pyrido[2,3-B]pyrazin-8-substituted compounds and their useCANCER REC TECH LTD·Filed 2013·Granted Dec 16, 2014·8 cites·20 claims
- 0587US8546387B2Pyrido[2,3-b]pyrazin-8-substituted compounds and their useSPRINGER CAROLINE JOY·Filed 2012·Granted Oct 1, 2013·11 cites·32 claims
- 0687US8383816B2Aryl-quinolyl compounds and their useCANCER REC TECH LTD·Filed 2009·Granted Feb 26, 2013·13 cites·29 claims
- 0785US9725447B21-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancerCANCER RES TECH LTD·Filed 2014·Granted Aug 8, 2017·8 cites·45 claims
- 0885US9439893B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyCANCER RES TECH LTD·Filed 2015·Granted Sep 13, 2016·4 cites·29 claims
- 0982US8815896B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapySPRINGER CAROLINE·Filed 2011·Granted Aug 26, 2014·7 cites·33 claims
- 1081US9708317B2Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivativesCANCER RES TECH LTD·Filed 2014·Granted Jul 18, 2017·2 cites·83 claims
- 1175US9820976B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyCANCER RESEARCH TECH LTD·Filed 2016·Granted Nov 21, 2017·1 cites·30 claims
- 1273US11325915B2Lysyl oxidase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2018·Granted May 10, 2022·1 cites·18 claims
- 1369US9540372B2Pyrido[2,3-b]pyrazin-8-substituted compounds and their useINST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)·Filed 2015·Granted Jan 10, 2017·1 cites·37 claims
- 1464US12060360B2Lysyl oxidase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2022·Granted Aug 13, 2024·0 cites·16 claims
- 1557US10100053B2Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-b]pyrazin-3-one derivativesCANCER RESEARCH TECH LTD·Filed 2017·Granted Oct 16, 2018·0 cites·2 claims
- 1648US10167282B21-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancerCANCER RESEARCH TECH LTD·Filed 2017·Granted Jan 1, 2019·0 cites·26 claims
- 1739US2011112110A1Antiproliferative compounds and therapeutic uses thereofUNIV MILANO BICOCCA·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alfonso Zambon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →